These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 39000222

  • 1. Anti-Persisters Activity of Lacticaseibacillus rhamnosus Culture Filtrates against Pseudomonas aeruginosa in Artificial Sputum Medium.
    Bianchi M, Esin S, Kaya E, Batoni G, Maisetta G.
    Int J Mol Sci; 2024 Jun 28; 25(13):. PubMed ID: 39000222
    [Abstract] [Full Text] [Related]

  • 2. An Antipersister Strategy for Treatment of Chronic Pseudomonas aeruginosa Infections.
    Koeva M, Gutu AD, Hebert W, Wager JD, Yonker LM, O'Toole GA, Ausubel FM, Moskowitz SM, Joseph-McCarthy D.
    Antimicrob Agents Chemother; 2017 Dec 28; 61(12):. PubMed ID: 28923873
    [Abstract] [Full Text] [Related]

  • 3. Use of artificial sputum medium to test antibiotic efficacy against Pseudomonas aeruginosa in conditions more relevant to the cystic fibrosis lung.
    Kirchner S, Fothergill JL, Wright EA, James CE, Mowat E, Winstanley C.
    J Vis Exp; 2012 Jun 05; (64):e3857. PubMed ID: 22711026
    [Abstract] [Full Text] [Related]

  • 4. Activity of Antibiotics against Pseudomonas aeruginosa in an In Vitro Model of Biofilms in the Context of Cystic Fibrosis: Influence of the Culture Medium.
    Diaz Iglesias Y, Van Bambeke F.
    Antimicrob Agents Chemother; 2020 Mar 24; 64(4):. PubMed ID: 32015047
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Antimicrobial activity of fosfomycin and tobramycin in combination against cystic fibrosis pathogens under aerobic and anaerobic conditions.
    McCaughey G, McKevitt M, Elborn JS, Tunney MM.
    J Cyst Fibros; 2012 May 24; 11(3):163-72. PubMed ID: 22138067
    [Abstract] [Full Text] [Related]

  • 10. Bacteriophages as potential antibiotic potentiators in cystic fibrosis: A new model to study the combination of antibiotics with a bacteriophage cocktail targeting dual species biofilms of Staphylococcus aureus and Pseudomonas aeruginosa.
    Wang Z, De Soir S, Glorieux A, Merabishvili M, Knoop C, De Vos D, Pirnay JP, Van Bambeke F.
    Int J Antimicrob Agents; 2024 Sep 24; 64(3):107276. PubMed ID: 39009289
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy of Aerosolized Rifaximin versus Tobramycin for Treatment of Pseudomonas aeruginosa Pneumonia in Mice.
    Kirby BD, Al Ahmar R, Withers TR, Valentine ME, Valentovic M, Long TE, Gaskins JR, Yu HD.
    Antimicrob Agents Chemother; 2019 Jul 24; 63(7):. PubMed ID: 31010865
    [Abstract] [Full Text] [Related]

  • 13. Role of Viscoelasticity in Bacterial Killing by Antimicrobials in Differently Grown Pseudomonas aeruginosa Biofilms.
    Rozenbaum RT, van der Mei HC, Woudstra W, de Jong ED, Busscher HJ, Sharma PK.
    Antimicrob Agents Chemother; 2019 Apr 24; 63(4):. PubMed ID: 30745390
    [Abstract] [Full Text] [Related]

  • 14. Effect of L-arginine on cystic fibrosis Pseudomonas aeruginosa biofilms.
    Eisha S, Morris AJ, Martin I, Yau YCW, Grasemann H, Waters V.
    Antimicrob Agents Chemother; 2024 Aug 07; 68(8):e0033624. PubMed ID: 39023260
    [Abstract] [Full Text] [Related]

  • 15. Determining effects of nitrate, arginine, and ferrous on antibiotic recalcitrance of clinical strains of Pseudomonas aeruginosa in biofilm-inspired alginate encapsulates.
    Jabalameli F, Emaneini M, Beigverdi R, Halimi S, Siroosi M.
    Ann Clin Microbiol Antimicrob; 2023 Jul 20; 22(1):61. PubMed ID: 37475017
    [Abstract] [Full Text] [Related]

  • 16. Low-Dose Nitric Oxide as Targeted Anti-biofilm Adjunctive Therapy to Treat Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis.
    Howlin RP, Cathie K, Hall-Stoodley L, Cornelius V, Duignan C, Allan RN, Fernandez BO, Barraud N, Bruce KD, Jefferies J, Kelso M, Kjelleberg S, Rice SA, Rogers GB, Pink S, Smith C, Sukhtankar PS, Salib R, Legg J, Carroll M, Daniels T, Feelisch M, Stoodley P, Clarke SC, Connett G, Faust SN, Webb JS.
    Mol Ther; 2017 Sep 06; 25(9):2104-2116. PubMed ID: 28750737
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Smith S, Waters V, Jahnke N, Ratjen F.
    Cochrane Database Syst Rev; 2020 Jun 10; 6(6):CD009528. PubMed ID: 32520436
    [Abstract] [Full Text] [Related]

  • 20. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V, Ratjen F.
    Cochrane Database Syst Rev; 2017 Oct 05; 10(10):CD009528. PubMed ID: 28981972
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.